Literature DB >> 17932966

Receipt of preventive health services by IBD patients is significantly lower than by primary care patients.

Lisbeth Selby1, Sunanda Kane, John Wilson, Purnima Balla, Brian Riff, Christopher Bingcang, Andrew Hoellein, Smita Pande, Willem J S de Villiers.   

Abstract

BACKGROUND: Persons with chronic diseases often do not receive preventive care at the same rate as the general population. Reasons for this are not clear. We conducted a cross-sectional survey of patients with inflammatory bowel disease (IBD) and controls to assess receipt of 10 preventive health services.
METHODS: From March through October 2006, IBD outpatients and primary care outpatients at the University of Kentucky (UK) were surveyed by trained clinicians, using chart data to augment patient response. A second sample of IBD patients from the University of Chicago was studied with a self-administered survey.
RESULTS: One hundred and seventeen IBD subjects were enrolled at UK, 125 IBD subjects were enrolled at UCH, and 100 control subjects were recruited from UK primary care clinics. The overall age-/sex-adjusted screening rate, as measured by the screening index, was significantly lower in UK IBD subjects than in UK controls (75.1% versus 83.9%, P = 0.0002). The UCH data showed a 67% overall age-/sex-adjusted screening rate. After adjusting for insurance status, the difference in screening rates was still lower for IBD patients than for controls (71% versus 78%; P = 0.022). Neither disease type nor disease control rating predicted screening rate.
CONCLUSIONS: Our data suggest IBD patients do not receive preventive services at the same rate as general medical patients. Preventive care is a facet of global IBD management that deserves further study.

Entities:  

Mesh:

Year:  2008        PMID: 17932966     DOI: 10.1002/ibd.20266

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  30 in total

Review 1.  Elderly patients and inflammatory bowel disease.

Authors:  Danielle Nimmons; Jimmy K Limdi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 2.  A Practical Guide to the Safety and Monitoring of New IBD Therapies.

Authors:  Benjamin Click; Miguel Regueiro
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

3.  Improving IBD Care: A Personalized Approach to Management.

Authors:  Stephen B Hanauer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-03

Review 4.  ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

Authors:  Francis A Farraye; Gil Y Melmed; Gary R Lichtenstein; Sunanda V Kane
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

Review 5.  Vaccination in the Elderly and IBD.

Authors:  Anthony J Choi; Preston Atteberry; Dana J Lukin
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

6.  Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice-results of a non-representative survey.

Authors:  Lea I Kredel; Oliver Schneidereit; Jörg C Hoffmann; Britta Siegmund; Jan C Preiß
Journal:  Int J Colorectal Dis       Date:  2018-12-07       Impact factor: 2.571

Review 7.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

8.  Suboptimal rates of cervical testing among women with inflammatory bowel disease.

Authors:  Millie D Long; Carol Q Porter; Robert S Sandler; Michael D Kappelman
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10-15       Impact factor: 11.382

Review 9.  Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?

Authors:  Jason S Reich; Francis A Farraye; Sharmeel K Wasan
Journal:  Dig Dis Sci       Date:  2016-04-09       Impact factor: 3.199

10.  Comparing guideline-based care quality for inflammatory bowel disease and rheumatoid arthritis patients within a medical home.

Authors:  Freddy Caldera; Sumona Saha; Arnold Wald; David M Cooley; Ying-Qi Zhao; Zhanhai Li; Christie M Bartels
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-04-12       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.